SCHEMBL8044830

SCHEMBL8044830

C1CCC2C[N]CCC2NC1

nearest known ligand 0.34

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
EPAS1 Q99814 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6486136 0.94 EPAS1 (0.32) EPAS1
SCHEMBL334605 0.85
SCHEMBL8062474 0.83 EPAS1 (0.34) EPAS1
SCHEMBL8055985 0.83 EPAS1 (0.36) EPAS1
SCHEMBL9557669 0.78 MBTD1 (0.35) EPAS1
SCHEMBL8056830 0.77 HRH4 (0.33) EPAS1
SCHEMBL477174 0.76
SCHEMBL3204034 0.76
SCHEMBL477175 0.76
SCHEMBL2095877 0.76

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6140333-A FOR TREATMENT AND/OR PROPHYLAXIS OF DISEASES INCLUDE SUCH RESPIRATORY DISEASES AS CHRONIC OBSTRUCTIVE PULMONARY DISEASES, CHRONIC BRONCHITIS, ASTHMA, CHRONIC RESPIRATORY OBSTRUCTION, PULMONARY FIBROSIS, PULMONARY EMPHYSEMA BANYU PHARMACEUTICAL CO LTD (JP) 2000-10-31 US disclosed